These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 16329043)

  • 1. Molecular alterations of monophasic synovial sarcoma: loss of chromosome 3p does not alter RASSF1 and MLH1 transcriptional activity.
    Pazzaglia L; Benassi MS; Ragazzini P; Gamberi G; Ponticelli F; Chiechi A; Hattinger CM; Morandi L; Alberghini M; Zanella L; Picci P; Mercuri M
    Histol Histopathol; 2006 Feb; 21(2):187-95. PubMed ID: 16329043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective evaluation of TLE1 as a diagnostic immunohistochemical marker in synovial sarcoma.
    Jagdis A; Rubin BP; Tubbs RR; Pacheco M; Nielsen TO
    Am J Surg Pathol; 2009 Dec; 33(12):1743-51. PubMed ID: 19809272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression profiling of synovial sarcoma by cDNA microarrays: association of ERBB2, IGFBP2, and ELF3 with epithelial differentiation.
    Allander SV; Illei PB; Chen Y; Antonescu CR; Bittner M; Ladanyi M; Meltzer PS
    Am J Pathol; 2002 Nov; 161(5):1587-95. PubMed ID: 12414507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Loss of heterozygosity of tumor suppressor genes at chromosome 3p in transitional cell carcinoma of urinary bladder].
    Xiao Z; Zhang J; Zheng S; Li C; He Z; Cheng S; Gao Y
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1375-7. PubMed ID: 12509916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic utility of reduced immunohistochemical expression of SMARCB1 in synovial sarcomas: a validation study.
    Ito J; Asano N; Kawai A; Yoshida A
    Hum Pathol; 2016 Jan; 47(1):32-7. PubMed ID: 26520417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E-cadherin gene mutations frequently occur in synovial sarcoma as a determinant of histological features.
    Saito T; Oda Y; Sugimachi K; Kawaguchi K; Tamiya S; Tanaka K; Matsuda S; Sakamoto A; Iwamoto Y; Tsuneyoshi M
    Am J Pathol; 2001 Dec; 159(6):2117-24. PubMed ID: 11733362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Densely methylated MLH1 promoter correlates with decreased mRNA expression in sporadic colorectal cancers.
    Furukawa T; Konishi F; Masubuchi S; Shitoh K; Nagai H; Tsukamoto T
    Genes Chromosomes Cancer; 2002 Sep; 35(1):1-10. PubMed ID: 12203784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Roles of immunohistochemistry and detection of SYT-SSX fusion gene in diagnosis of synovial sarcoma].
    Sun Y; Sun BC; Zhao XL; Wang J; Chen J; Li XQ; Feng YM; Fang ZW; Hao XS
    Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):480-4. PubMed ID: 17845763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-abdominal synovial sarcoma: a clinicopathological study.
    Fisher C; Folpe AL; Hashimoto H; Weiss SW
    Histopathology; 2004 Sep; 45(3):245-53. PubMed ID: 15330802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA content and morphological parameters in synovial sarcoma and synovioma.
    Lu C; Xia J; Yang M
    Chin Med J (Engl); 1995 Oct; 108(10):760-3. PubMed ID: 8565662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma.
    Kawai A; Woodruff J; Healey JH; Brennan MF; Antonescu CR; Ladanyi M
    N Engl J Med; 1998 Jan; 338(3):153-60. PubMed ID: 9428816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsatellite instability and MLH1 promoter methylation in human retinoblastoma.
    Choy KW; Pang CP; Fan DS; Lee TC; Wang JH; Abramson DH; Lo KW; To KF; Yu CB; Beaverson KL; Cheung KF; Lam DS
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3404-9. PubMed ID: 15452042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of SYT-SSX fusion transcripts in archival synovial sarcomas by real-time reverse transcriptase-polymerase chain reaction.
    Bijwaard KE; Fetsch JF; Przygodzki R; Taubenberger JK; Lichy JH
    J Mol Diagn; 2002 Feb; 4(1):59-64. PubMed ID: 11826189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression.
    Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Kawai A; Sonobe H; Takahira T; Kobayashi C; Yamamoto H; Tamiya S; Hirohashi S; Iwamoto Y; Tsuneyoshi M
    Am J Surg Pathol; 2007 Jan; 31(1):85-94. PubMed ID: 17197923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
    Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
    Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraarticular synovial sarcoma.
    McKinney CD; Mills SE; Fechner RE
    Am J Surg Pathol; 1992 Oct; 16(10):1017-20. PubMed ID: 1384367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The classic prognostic factors tumor stage, tumor size, and tumor grade are the strongest predictors of outcome in synovial sarcoma: no role for SSX fusion type or ezrin expression.
    ten Heuvel SE; Hoekstra HJ; Bastiaannet E; Suurmeijer AJ
    Appl Immunohistochem Mol Morphol; 2009 May; 17(3):189-95. PubMed ID: 18997619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microsatellite instability is not an uncommon finding in adult de novo acute myeloid leukemia.
    Nomdedéu JF; Perea G; Estivill C; Lasa A; Carnicer MJ; Brunet S; Aventín A; Sierra J
    Ann Hematol; 2005 Jun; 84(6):368-75. PubMed ID: 15789228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of the SYT-SSX fusion transcripts in formaldehyde-fixed, paraffin-embedded tissue: a reverse transcription polymerase chain reaction amplification assay useful in the diagnosis of synovial sarcoma.
    Lasota J; Jasinski M; Debiec-Rychter M; Szadowska A; Limon J; Miettinen M
    Mod Pathol; 1998 Jul; 11(7):626-33. PubMed ID: 9688183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Abnormalities of tumor suppressor genes at chromosome 3p in lung cancer].
    Li L; An Q; Feng X
    Zhonghua Yi Xue Za Zhi; 2001 Apr; 81(7):399-401. PubMed ID: 11798905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.